Stable group (n = 99) | Unstable group (n = 17) | P value | |
---|---|---|---|
Age (years) | 54.0 (36.0–62.0) | 59.0 (48.0–68.0) | 0.057 |
Female [n (%)] | 39 (39.4) | 13 (76.5) | 0.010* |
Body weight (kg) | 65.6 (12.6) | 63.2 (10.0) | 0.449 |
BMI (kg/m2) | 24.3 (3.6) | 26.1 (4.0) | 0.058 |
Classification by BMI | |||
Underweight [n (%)] | 5 (5.1) | 0 | 0.008† |
Normal weight [n (%)] | 52 (52.5) | 5 (29.4) | |
Overweight [n (%)] | 38 (38.4) | 8 (47.1) | |
Obesity [n (%)] | 4 (4.0) | 4 (23.5) | |
Underlying disease [n (%)] | |||
Hypertension | 20 (20.2) | 8 (47.1) | 0.037* |
History of CAD | 4 (4.0) | 1 (5.9) | 0.764 |
Diabetes mellitus | 12 (12.1) | 3 (17.6) | 0.813 |
Preoperative laboratory test | |||
AST (IU/L) | 23.0 (20.0–28.0) | 25.0 (20.5–34.0) | 0.296 |
ALT (IU/L) | 22.0 (18.0–29.0) | 21.0 (19.0–38.0) | 0.550 |
Albumin (g/dL) | 4.6 (4.3–4.7) | 4.4 (4.3–4.6) | 0.094 |
Surgery time (min) | 37.0 (25.0–56.0) | 30.0 (25.0–53.5) | 0.734 |
PACU stay (min) | 62.0 (53.0–74.0) | 57.0 (50.0–93.0) | 0.896 |
Hospital stay (days) | 6.0 (4.0–8.0) | 6.0 (5.0–9.5) | 0.195 |
Time to hemodynamic instability after initiating DMED administration (min) | N/A | 67.0 (37.4–96.6) | N/A |